ACE2 and COVID-19: Evaluated by molecular docking analysis, dithymoquinone (a quinone, Figure 2) showed neuroprotective responses (Zhang et al., 2018; Talebi et al., 2020) through binding to ACE2, to show key roles in the prevention and treatment of COVID-19 (Wahedi et al., 2020; Ahmad et al., 2020).